Development and Validation of a Stability-indicating Method for Neostigmine Bromide: Separation, Identification and Characterization of Degradation Product using LC-MS and ESI-Q-TOF-MS/MS (original) (raw)

Review: Development of forced degradation studies of drugs

Scholar Science Journals

View PDFchevron_right

The use of liquid chromatography±mass spectrometry for the identi®cation of drug degradation products in pharmaceutical formulations

Marco Garzotti

View PDFchevron_right

Current Trend in Performance of Forced Degradation Studies for Drug Substance and Drug Product’s

Rajveer Bhaskar

Journal of Drug Delivery and Therapeutics

View PDFchevron_right

Development of forced degradation and stability indicating studies of drugs—A review

Dr. Prajesh Prajapati

Journal of Pharmaceutical Analysis, 2014

View PDFchevron_right

Forced Degradation Study: An Important Tool in Drug Development AB Roge, PS Tarte, MM Kumare, Dr. G R Shendarkar, Dr. S M Vadvalkar

Mangesh Kumare

View PDFchevron_right

A NOVEL STABILITY-INDICATING RP-UPLC METHOD FOR THE QUANTIFICATION OF IMPURITIES AND A NEW QDa MASS DETECTOR COUPLED WITH LC-PDA FOR IDENTIFICATION OF MASS OF DEGRADATION PRODUCTS IN A FIXED DOSE COMBINATION OF EMPAGLIFLOZIN AND LANIGLIPTIN TABLETS USED AS SECOND-LINE THERAPY FOR TYPE-2 DIABETES

varaprasad jagadabi

International Research Journal of Pharmacy, 2018

View PDFchevron_right

Kinetic Degradation Study of Dapagliflozin Coupled with UHPLC Separation in the Presence of Major Degradation Product and Metformin

Wafaa A Zaghary

Chromatographia, 2019

View PDFchevron_right

Author's Accepted Manuscript Development of forced degradation and stability indicating studies of drugs – A review

yang gattuso

View PDFchevron_right

An Introduction to Forced degradation studies for drug substances and drug products

MUSKAN singh

Journal of emerging technologies and innovative research, 2021

View PDFchevron_right

Technical Considerations of Forced Degradation Studies of New Drug Substances and Product: Regulatory Perspectives

Parul Singh

Journal of Drug Delivery and Therapeutics, 2018

View PDFchevron_right

Forced degradation study of efonidipine HCl ethanolate, characterization of degradation products by LC-Q-TOF-MS and NMR

Charu Pandya

Journal of Applied Pharmaceutical Science, 2020

View PDFchevron_right

Strategy for identification and characterization of small quantities of drug degradation products using LC and LC-MS: Application to valsartan, a model drug

Saranjit Singh

Drug Testing and Analysis, 2010

View PDFchevron_right

Novel validated stability-indicating UPLC method for the determination of Metoclopramide and its degradation impurities in API and pharmaceutical dosage form Prathyusha Sowjanya a,*, Palani Shanmugasundaram , Petla Naidu , Sanjeev Kumar Singamsetty

Palani Shanmugasundaram

journal of pharmacy research 6 (2013) 765 e773, 2013

View PDFchevron_right

A review article – development of forced degradation and stability indicating studies for drug substance and drug product

IJRPP Journal

View PDFchevron_right

IDENTIFICATION OF DABIGATRAN ETEXILATE MAJOR DEGRADATION PATHWAYS BY LIQUID CHROMATOGRAPHY COUPLED TO MULTI STAGE HIGH-RESOLUTION MASS SPECTROMETRY

caroline chodur

RSC Adv., 2015

View PDFchevron_right

Stress Degradation Behavior of Desipramine Hydrochloride and Development of Suitable Stability-Indicating LC Method

Girish Deshpande

Chromatographia, 2008

View PDFchevron_right

Characterization of forced degradation products of ketorolac tromethamine using LC/ESI/Q/TOF/MS/MS and in silico toxicity prediction

Divya Dornala

Journal of Mass Spectrometry, 2014

View PDFchevron_right

Forced degradation of nepafenac: Development and validation of stability indicating UHPLC method

Irena Nekola

View PDFchevron_right

New Validated RP-HPLC Method for Quantification of Rupatadine FumarateImpurities in Solid Dosage Form Supported By Forced Degradation Studies

Rajan Rele

Der Pharmacia Lettre, 2016

View PDFchevron_right

Chromatographic separation of tiropramide hydrochloride and its degradation products along with their structural characterization using LC-QTOF-MS/MS and NMR

Bhoopendra Singh Kushwah

Research Square (Research Square), 2022

View PDFchevron_right

Forced degradation studies for Drug Substances and Drug Products-Scientific and Regulatory Considerations

Kumar Sourabh Jain

View PDFchevron_right

Systematic strategies for degradation kinetic study of pharmaceuticals: an issue of utmost importance concerning current stability analysis practices

Tarang Jadav

Journal of Analytical Science and Technology, 2022

View PDFchevron_right

In vitro Comparative Degradation Study of Different Brands of Domperidone Using UV Spectrophotometer

Abul Hasanat

View PDFchevron_right

Forced Degradation Study for Simultaneous Quantification of Aspirin and Omeprazole in Pharmaceutical Dosage form by RP-HPLC

chandni chandarana

Journal of Pharmaceutical Research International

View PDFchevron_right

ANALYTICAL ASSAY METHOD VALIDATION AND FORCED DEGRADATION BEHAVIOR OF S (-) AMLODIPINE BESILATE AND LOSARTAN POTASSIUM FROM FIXED DOSE COMBINATION

INTERNATIONAL JOURNAL

View PDFchevron_right

Development and validation of a stability-indicating RP-HPLC method for the identification, determination of related substances and assay of dimethyl fumarate in drug substance

Samit Kumar

Annales Pharmaceutiques Françaises, 2021

View PDFchevron_right

Structural elucidation of degradation products of a benzopyridooxathiazepine under stress conditions using electrospray orbitrap mass spectrometry – Study of degradation kinetic

Jean-françois Goossens

European Journal of Pharmaceutical Sciences, 2012

View PDFchevron_right

Identification of Degradation Products in Cyclophosphamide API by LC-QTOF Mass Spectrometry Identification of Degradation Products in Cyclophosphamide API by LC-QTOF Mass Spectrometry

shiva gudlawar

View PDFchevron_right

DEVELOPMENT AND VALIDATION OF A STABILITY-INDICATING RELATED SUBSTANCES OF TRANDOLAPRIL BY RP-HPLC AND ITS DEGRADATION Original Article

International Journal of Applied Pharmaceutics (IJAP)

International Journal of Applied Pharmaceutics, 2021

View PDFchevron_right

Quality Control Assessment of Dutasteride and Silodosin in Capsules and Tablets Employing a Novel Developed HPLC Technique; Evaluation of Stabilities of Dutasteride and Silodosin in Accelerated Degradation

Balaji Gupta Tiruveedhi

International Journal of Applied Pharmaceutics, 2023

View PDFchevron_right

QUALITY CONTROL ASSESSMENT OF DUTASTERIDE AND SILODOSIN IN CAPSULES AND TABLETS EMPLOYING A NOVEL DEVELOPED HPLC TECHNIQUE; EVALUATION OF STABILITIES OF DUTASTERIDE AND SILODOSIN IN ACCELERATED DEGRADATION Original Article

International Journal of Applied Pharmaceutics (IJAP)

International Journal of Applied Pharmaceutics, 2023

View PDFchevron_right

Forced degradation studies of lansoprazole using LC-ESI HRMS and 1 H-NMR experiments: in vitro toxicity evaluation of major degradation products

Nagesh Narayana

Journal of Mass Spectrometry, 2017

View PDFchevron_right

Impurity profiling of trandolapril under stress testing: Structure elucidation of by-products and development of degradation pathway

Maha Dendeni

International journal of pharmaceutics, 2012

View PDFchevron_right

LC-MS/MS Characterization of Forced Degradation Products of Repaglinide Quality by Design Approach for Stability-Indicating LC Method Development and Validation for Degradation Products

Saeed Albaseer

Analytical Chemistry Letters, 2020

View PDFchevron_right

ASSAY METHOD DEVELOPMENT AND VALIDATION OF CILNIDIPINE AND RAMIPRIL, CHARACTERIZATION OF ITS DEGRADANTS BY USING LC-MS/MS Original Article

International Journal of Applied Pharmaceutics (IJAP)

International Journal of Applied Pharmaceutics, 2022

View PDFchevron_right